News

Deal Announcements

AltheaDx Raises $6 Million Series A Venture Capital

Thursday, April 15, 2010 5:56:00 AM PDT | VentureDeal Staff
San Diego, California  --  biotechnology development company AltheaDx has secured $6 million in its first round of institutional venture capital investment.

AltheaDx has developed a proprietary gene expression profiling technology for differential diagnosis of pediatric cancers and improve diagnosis of prostate cancer.

Telegraph Hill Partners led the round, which included other undisclosed investors.  The companies said it would use the funding proceeds to support its existing partnerships.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1